During the past decade, Mater QRI conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mater QRI" #1 collaborator was "Australasian Leukaemia and Lymphoma Group" with 2 trials as a collaborator, "3M" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator and "Australasian Radiation Oncology Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Mater QRI" are "Adenocarcinoma of Rectum" (1 trials), "Breast Cancer" (1 trials), "Lymph Node Disease" (1 trials), "Malignant Melanoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Mater QRI" in a lesser frequency.

Most popular intervention types in "Mater QRI" are "Radiation" (8 trials), "Drug" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Radiotherapy" (4 trials), "Carboplatin" (1 trials), "Cavilon (TM) Durable Barrier Cream" (1 trials), "Concurrent Chemotherapy" (1 trials) and "Conventional external beam therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mater QRI" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mater QRI". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Mater QRI, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mater QRI, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".